Trial intelligence / Profile preview

Oxytocin Effects on Approach Behavior in Complicated Grief

NCT04505904Completed

Sponsor
University of Arizona
Start
Mar 2015
Primary completion
May 2017
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin nasal spray in prolonged grief disorder (PGD) (2 arms), sponsored by University of Arizona. Primary endpoint: Reaction Time of a Push or Pull of a Joystick at 120 minutes. Started Mar 2015; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

prolonged grief disorder (PGD)

Beyond the preview

Go deeper on NCT04505904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04505904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call